Parallax Volatility Advisers’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-70,200
Closed -$1.7M 1793
2024
Q4
$1.7M Buy
70,200
+38,100
+119% +$944K ﹤0.01% 1174
2024
Q3
$591K Sell
32,100
-172,000
-84% -$3.08M ﹤0.01% 1484
2024
Q2
$4.12M Buy
204,100
+124,100
+155% +$2.06M 0.01% 795
2024
Q1
$1.24M Sell
80,000
-7,100
-8% -$80K ﹤0.01% 1177
2023
Q4
$775K Hold
87,100
﹤0.01% 1492
2023
Q3
$548K Buy
87,100
+50,000
+135% +$372K ﹤0.01% 1564
2023
Q2
$349K Hold
37,100
﹤0.01% 1768
2023
Q1
$368K Buy
+37,100
New +$325K ﹤0.01% 1823

Other funds holding HIMS

Parallax Volatility Advisers's HIMS Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 80 shares — an estimated $1.93K sold.

Parallax Volatility Advisers first reported a position in HIMS in Q3 2021 and held it in 7 quarters. The position peaked at $759K in Q3 2023. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 80 Hims & Hers Health shares in Q1 2025, an estimated $1.93K.
  • Parallax Volatility Advisers first reported a position in Hims & Hers Health in Q3 2021 and held it in 7 quarters.
  • Parallax Volatility Advisers's Hims & Hers Health position peaked at $759K in Q3 2023.
  • 429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.